ストックスクリーナーアプリを入手
9.14
5.58%
-0.54
アフターアワーズ：
9.14
前日終値:
$9.68
開ける：
$9.68
24時間の取引高:
1.63M
Relative Volume:
1.39
時価総額：
$690.56M
収益：
$11.40B
当期純損益:
$-95.73M
株価収益率:
-3.7306
EPS:
-2.45
ネットキャッシュフロー:
$-64.37M
1週間 パフォーマンス:
-5.19%
1か月 パフォーマンス:
+39.54%
6か月 パフォーマンス:
+24.86%
1年 パフォーマンス:
+0.44%
1日の値動き範囲:
$9.02
$9.70
1週間の範囲:
$9.02
$10.09
52週間の値動き範囲:
$4.70
$10.44
Mind Medicine Inc Stock (MNMD) Company Profile
MNMD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
9.14 | 731.36M | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 118.34B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.14 | 60.31B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.35B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.79 | 36.43B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.74 | 31.87B | 3.81B | -644.79M | -669.77M | -6.24 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-28 | 開始されました | Evercore ISI | Outperform |
| 2024-12-20 | 開始されました | Chardan Capital Markets | Buy |
| 2024-10-14 | 再開されました | Leerink Partners | Outperform |
| 2024-07-24 | 開始されました | ROTH MKM | Buy |
| 2024-05-29 | 開始されました | Robert W. Baird | Outperform |
| 2024-04-15 | 開始されました | Leerink Partners | Outperform |
| 2023-12-05 | 開始されました | Canaccord Genuity | Buy |
| 2022-12-09 | 再開されました | ROTH Capital | Buy |
| 2022-11-16 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-08-26 | 開始されました | Oppenheimer | Outperform |
| 2022-08-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-05-04 | 開始されました | ROTH Capital | Buy |
| 2021-06-28 | 開始されました | Maxim Group | Buy |
すべてを表示
Mind Medicine Inc (MNMD) 最新ニュース
Custom Dashboard Highlights Mind Medicine (MindMed) Inc. Price MomentumConservative Long Term Growth Plans Under Review - metal.it
Mind Medicine MNMD 2025Q2 Earnings Preview Upside Potential on Strong Analyst Ratings - AInvest
Published on: 2025-07-29 03:31:44 - metal.it
Why is Mind Medicine (MindMed) Inc. stock attracting strong analyst attentionFinancial News Tracker With High Returns - jammulinksnews.com
How does Mind Medicine (MindMed) Inc. generate profit in a changing economyExpert guidance for superior capital growth - jammulinksnews.com
When is Mind Medicine (MindMed) Inc. stock expected to show significant growthCapitalize on strong market momentum - jammulinksnews.com
What are analysts’ price targets for Mind Medicine (MindMed) Inc. in the next 12 monthsUnlock powerful portfolio optimization tools - jammulinksnews.com
How many analysts rate Mind Medicine (MindMed) Inc. as a “Buy”Discover undervalued stocks before they soar - jammulinksnews.com
What risks could impact Mind Medicine (MindMed) Inc. stock performanceFree Deep Market Trend Analysis - metal.it
Is Mind Medicine (MindMed) Inc. a good long term investmentTriple-digit returns - PrintWeekIndia
Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Mind Medicine: Heading In The Right Direction (NASDAQ:MNMD) - Seeking Alpha
MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025 - Business Wire
All You Need to Know About Mind Medicine MindMed (MNMD) Rating Upgrade to Buy - MSN
What analysts say about Mind Medicine (MindMed) Inc. stockExplosive capital appreciation - jammulinksnews.com
Mind Medicine (MindMed) Inc. Stock Analysis and ForecastExplosive capital appreciation - jammulinksnews.com
Mind Medicine (MindMed) Stock (MNMD) Opinions on Psychedelic Therapy Political Momentum - Nasdaq
(MNMD) Trading Signals - news.stocktradersdaily.com
What drives Mind Medicine (MindMed) Inc. stock priceLightning-fast capital gains - jammulinksnews.com
Don't Trip. These Psychedelic Stocks May Have Some Life in Them Yet - US News Money
Mind Medicine stock rises as lawmakers discuss psychedelic therapy for veterans - Investing.com Canada
MindMed Announces New Employee Inducement Grants - Business Wire
Evercore ISI Sticks to Its Buy Rating for Mind Medicine (MNMD) - The Globe and Mail
Mind Medicine Inc.(NasdaqGS: MNMD) added to Russell 3000E Value Index - MarketScreener
Mind Medicine Executives Sell Shares to Cover Tax Obligations - TradingView
Psychedelic medicine stocks fall following Compass depression asset data (ATAI:NASDAQ) - Seeking Alpha
(MNMD) Trading Report - news.stocktradersdaily.com
Incannex forms joint venture with Mind Medicine Australia for clinic By Investing.com - Investing.com South Africa
Mind Medicine at H.C. Wainwright: Strategic Advances in Neuropsychiatry By Investing.com - Investing.com Canada
Incannex forms joint venture with Mind Medicine Australia for clinic - Investing.com
Incannex Healthcare Forms Joint Venture With Mind Medicine Australia To Expand Access To Psychedelic-Assisted Therapy - MarketScreener
Mind Medicine Inc (MNMD) 財務データ
収益
当期純利益
現金流量
EPS
10.28%
2.59%
大文字化:
|
ボリューム (24 時間):